Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial - Concepedia

Concepedia

Publication | Open Access

Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

DOI Full Paper Access

180

Citations

21

References

2016

Year

Jozef Bartúnek, André Terzic, Beth A. Davison, Gerasimos Filippatos, S. Radovanović, Branko Beleslin, Béla Merkely, Piotr Musiałek, Wojciech Wojakowski, Péter Andréka,

European Heart Journal

Abstract

The primary endpoint was neutral, with safety demonstrated across the cohort. Further evaluation of cardiopoietic cell therapy in patients with elevated end-diastolic volume is warranted.

References

	Year	Citations

Page 1